Observational study of dronedarone in Taiwanese patients with atrial fibrillation
ConclusionThis six-month study showed dronedarone to be relatively safe and efficacious and to improve quality-of-life in Taiwanese patients with atrial fibrillation. Odds of treatment success were related to the patient's gender, age, and AF type.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Atrial Fibrillation | Cardiology | Cardiovascular | General Medicine | Heart | Study | Taiwan Health